Prescription drug · NDA
Pliaglis NDC 71085-100
lidocaine and tetracaine · Lidocaine 70 mg/g; Tetracaine 70 mg/g · Cream · Topical · IPG PHARMACEUTICALS, INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71085-100-30 | 71085010030 | 1 TUBE in 1 CARTON (71085-100-30) / 30 g in 1 TUBEMarketed from Mar 6, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pliaglis
- Generic name (nonproprietary)
- lidocaine and tetracaine
- Active ingredients
- Lidocaine — 70 mg/gTetracaine — 70 mg/g
- Dosage form
- Cream
- Route
- Topical
- Labeler
- IPG PHARMACEUTICALS, INC.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021717
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Esters (Chemical structure)Local Anesthesia (Physiologic effect)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 71085-100_4c97e0ed-1d3a-44af-e063-6294a90ae75fSPL ID 4c97e0ed-1d3a-44af-e063-6294a90ae75fSPL set ID d854faa5-0af8-4684-b5cd-a0b8a91fb7cdRxCUI 687443, 728126UNII 98PI200987, 0619F35CGV
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic; Ester Local Anesthetic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471085010030followed by a unit qualifier and the quantityPackage 71085-0100-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
PLIAGLIS is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. PLIAGLIS is a combination of lidocaine, an amide local anesthetic, and tetracaine, an ester local anesthetic, indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. ( 1 )
Excerpt only. Read the full label for complete information.